|
XPO1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.65643063102061E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.60479979200079E-10 |
| Normal-vs-Stage2 |
3.010300E-04 |
| Normal-vs-Stage3 |
1.87060999999877E-05 |
| Normal-vs-Stage4 |
3.303700E-03 |
| Stage1-vs-Stage2 |
2.484000E-01 |
| Stage1-vs-Stage3 |
9.071600E-01 |
| Stage1-vs-Stage4 |
2.947400E-01 |
| Stage2-vs-Stage3 |
3.901400E-01 |
| Stage2-vs-Stage4 |
9.046200E-01 |
| Stage3-vs-Stage4 |
3.554000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.92335036786062E-12 |
| Normal-vs-AfricanAmerican |
5.22769999511397E-08 |
| Normal-vs-Asian |
1.61708999999455E-05 |
| Caucasian-vs-AfricanAmerican |
8.488600E-01 |
| Caucasian-vs-Asian |
4.458000E-01 |
| AfricanAmerican-vs-Asian |
4.550400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.560063686185E-12 |
| Normal-vs-Female |
9.60131973926082E-12 |
| Male-vs-Female |
2.025200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.14430000036836E-07 |
| Normal-vs-Extreme_Weight |
1.26080001994211E-09 |
| Normal-vs-Obese |
4.81009998498649E-09 |
| Normal-vs-Extreme_Obese |
1.237610E-03 |
| Normal_Weight-vs-Extreme_Weight |
6.530400E-01 |
| Normal_Weight-vs-Obese |
9.663400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.713800E-01 |
| Extreme_Weight-vs-Obese |
6.500200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.729400E-01 |
| Obese-vs-Extreme_Obese |
4.574000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.03999999999205E-05 |
| Normal-vs-Age(41-60Yrs) |
1.77047265736974E-12 |
| Normal-vs-Age(61-80Yrs) |
4.7935000413446E-10 |
| Normal-vs-Age(81-100Yrs) |
1.932010E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.653820E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.921700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.891900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.246000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.994770E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.571200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62536650805123E-12 |
| Normal-VS-Type2 PRCC |
6.811700E-04 |
| Normal-VS-KIRP CIMP |
3.05489999963271E-07 |
| Normal-VS-Unclassified PRCC |
3.72510000000714E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.14029999997989E-07 |
| Type1 PRCC-VS-KIRP CIMP |
7.724000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.740820E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.142300E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.326300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.696000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.66079999994484E-06 |
| Normal-vs-N1 |
1.51688999999733E-05 |
| Normal-vs-N2 |
3.882900E-03 |
| N0-vs-N1 |
1.147700E-02 |
| N0-vs-N2 |
6.685800E-01 |
| N1-vs-N2 |
4.814000E-01 |
|
|
